A MILTON Keynes broker has helped raise more than half a million pounds for cancer research.
Towergate Risk Solutions, of Avebury Boulevard in the city centre, has organised events during the last three years that have helped to bring in more than £541,000 to be used to fund a specific project at the charity Cancer Research UK.
The company is a part of the Towergate Partnership, Europe’s largest independently owned insurance intermediary. It held a range of staff fundraising activities in the local community and encouraged client donations.
The money raised by Towergate Milton Keynes is providing funding towards a team of top scientists headed up by Professor Adrian Harris who are carrying out world-class research. This includes looking at ways to block tumours from hijacking the blood supply which can then grow and spread round the body.
Joe Thelwell, MD of Towergate Risk Solutions Milton Keynes said: “One in three of us will get cancer at some point in our lives. Most of us know someone who has had cancer and has perhaps had the support of a local hospice. So we are truly thankful to our staff and clients for their hard work and donations to help support this fantastic cause”.
Professor Adrian Harris said, “We’re starting to see some really exciting results from our research. My team are investigating ways to block tumour growth by cutting off the blood supply. In a recent early stage clinical trial, we’ve seen encouraging responses from a potential new cancer treatment we are investigating that targets a tumour’s blood vessels. We are really keen to build on these results, and I really welcome Towergate Charitable Foundation’s commitment to support our work for another two years. This will build on the incredible £541,000 they have raised so far.”
Harpal Kumar, chief executive of Cancer Research UK said: “We are incredibly proud of our partnership with the Towergate Charitable Foundation. To have raised over £541,000 in the last three years is terrific and a testament to the commitment of Towergate’s staff and customers. The funds raised help Professor Adrian Harris take forward his life-saving research around preventing tumour growth by blocking its blood supply.”